Register to view the archived recording here.
Compandia Touts Bioinformatics as Differentiator in Biomarker Discovery Market
The company was founded around 18 months ago with the goal of using artificial neural network technology to identify biomarkers in high-dimensional data sets generated by mass spectrometry, microarrays, next-generation sequencing, and other high-throughput experimental platforms.
New to GenomeWeb? Register here quickly.